Relmada Therapeutics(RLMD)
CORAL GABLES, FL
BiotechnologyFocus: Small Molecules for Pain
Relmada Therapeutics is a life sciences company focused on Small Molecules for Pain.
OncologyNeurology
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
0
Pipeline & Clinical Trials
REL-1017
Major Depressive DisorderClinical Trials (1)
NCT06009003Individual Patient Esmethadone (REL-1017) Expanded Access Program
N/AREL-1017
Neuropathic PainClinical Trials (1)
NCT03637361Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of REL-1017 (d-Methadone)
Phase 1REL-1017
Neuropathic PainClinical Trials (1)
NCT03638869Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone)
Phase 1REL-1017
Depressive Disorder, MajorClinical Trials (1)
NCT03051256Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD
Phase 2NDV01 intravesical controlled release formulation of gemcitabine and docetaxel
Non Muscle Invasive Bladder CancerClinical Trials (1)
NCT06663137Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC
Phase 2REL-1017
Major Depressive DisorderClinical Trials (1)
NCT05081167A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD)
Phase 3REL-1017
Major Depressive DisorderClinical Trials (1)
NCT04855760Safety of REL-1017 for Major Depressive Disorder
Phase 3REL-1017
Major Depressive DisorderClinical Trials (1)
NCT04688164A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)
Phase 3Phase 3
Clinical Trials (1)
NCT07342517A Phase 3 Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy
Phase 3Clinical Trials (1)
NCT07313891A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2007
Portfolio: 10 clinical trials
SEC Filings: 2 available